Evaluation of Safety, Tolerability, Reactogenicity, Immunogenicity of Baiya SARS-CoV-2 Vax 2 as a Booster for COVID-19

NCT05873374 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Vaccine
COVID-19

Interventions

BIOLOGICAL: 50 μg Baiya SARS-CoV-2 Vax 2
OTHER: Placebo

Sponsor

Baiya Phytopharm Co., Ltd.